Showing results (861-870 of 65,137) with videos related to

Sort By:
Pageof 6,514
The American Journal of Cardiology|August 2, 2005
Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillationLasse S Ravn, Jacob Hofman-Bang, Ulrik Dixen, et al.
Scandinavian Journal of Gastroenterology|June 1, 1994
Prospective study of prevalence and endoscopic and histopathologic characteristics of duodenal polyps in patients submitted to upper endoscopyJ M Jepsen, M Persson, N O Jakobsen, et al.
Heliyon|March 22, 2018
CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathologyMads N Olesen, Josefine R Christiansen, Steen Vang Petersen, et al.
European Radiology Experimental|April 9, 2021
Breast cancer: comparison of quantitative dual-layer spectral CT and axillary ultrasonography for preoperative diagnosis of metastatic axillary lymph nodesThomas Winther Buus, Mads Sandahl, Kennet Sønderstgaard Thorup, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2006
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kineticsMorten B Krag, Lars C Gormsen, Zengkui Guo, et al.
Clinical Kidney Journal|January 8, 2024
Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort studyAne Emilie Friis Vestergaard, Simon Kok Jensen, Uffe Heide-Jørgensen, et al.
Frontiers in Plant Science|February 20, 2018
The Dangers of Being a Small, Oligotrophic and Light Demanding Freshwater Plant across a Spatial and Historical Eutrophication Gradient in Southern ScandinaviaKaj Sand-Jensen, Hans Henrik Bruun, Tora Finderup Nielsen, et al.
The International Journal of Neuropsychopharmacology|November 19, 2015
Anxiolytic-Like Effects of Increased Ghrelin Receptor Signaling in the AmygdalaMorten Jensen, Cecilia Ratner, Olga Rudenko, et al.
JAMA Internal Medicine|January 20, 2026
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 DiabetesSimon K Jensen, Uffe Heide-Jørgensen, Ina T Andersen, et al.
Clinical and Experimental Rheumatology|August 30, 2017
Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritisAnne Sofie Siebuhr, Cecilie F Kjelgaard-Petersen, Shu Sun, et al.
Pageof 6,514